(ISSN 2573-4407)
OBM Neurobiology is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. By design, the scope of OBM Neurobiology is broad, so as to reflect the multidisciplinary nature of the field of Neurobiology that interfaces biology with the fundamental and clinical neurosciences. As such, OBM Neurobiology embraces rigorous multidisciplinary investigations into the form and function of neurons and glia that make up the nervous system, either individually or in ensemble, in health or disease. OBM Neurobiology welcomes original contributions that employ a combination of molecular, cellular, systems and behavioral approaches to report novel neuroanatomical, neuropharmacological, neurophysiological and neurobehavioral findings related to the following aspects of the nervous system: Signal Transduction and Neurotransmission; Neural Circuits and Systems Neurobiology; Nervous System Development and Aging; Neurobiology of Nervous System Diseases (e.g., Developmental Brain Disorders; Neurodegenerative Disorders).
OBM Neurobiology publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). Although the OBM Neurobiology Editorial Board encourages authors to be succinct, there is no restriction on the length of the papers. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Special Issue
Advances in Neuropharmacology and Neurotoxicology: From Experimental Mechanisms to Clinical and Environmental Health
Submission Deadline: August 31, 2027 (Open) Submit Now
Guest Editors
Upaka Rathnayake, PhD
Professor, Department of Civil Engineering and Construction, Faculty of Engineering and Design, Atlantic Technological University, Sligo, Ireland
Research Interests: Climate analysis; multi-objective optimization; soft computing techniques; explainable artificial intelligence; health care analytics
Erinda Lika, PhD
Professor, Department of Veterinary Preclinical Modules, Faculty of Veterinary Medicine, Agricultural University of Tirana (UBT), Tirana, Albania
Research Interests: Pharmacology; clinical pharmacology/neuropharmacology; experimental pharmacology; ecotoxicology; pharmacovigilance, eco-pharmacovigilance, food toxicology; antimicrobic resistance
Valerii O. Erkudov, PhD
Assistant Professor, St. Petersburg State Pediatric Medical University, Department of Normal Physiology, Saint Petersburg, Russia
Research Interests: Environmental physiology; ecological physiology, public health, AI in health, clinical medicine
About This Topic
The health of the nervous system is increasingly influenced by interactions between therapeutic agents, environmental contaminants, toxic substances, and biological factors. This Special Issue highlights recent advances in neuropharmacology and neurotoxicology, with emphasis on understanding how drugs and potentially harmful chemical or biological agents affect the nervous system and how these effects can be predicted, prevented, and managed.
Topics include experimental and clinical neuropharmacology, mechanisms of neurotoxicity, pharmacokinetics and pharmacodynamics of neuroactive compounds, adverse neurological effects of pharmaceuticals, environmental and food-related neurotoxicants, oxidative stress and neuroinflammation, and experimental models for neurological safety and toxicity assessment.
We particularly welcome studies applying artificial intelligence (AI), machine learning, and computational approaches to neuropharmacology and neurotoxicology. Areas of interest include AI-assisted drug discovery and repurposing, prediction of neurotoxicity and adverse neurological effects, computational pharmacokinetic/pharmacodynamic modelling, biomarker discovery, image analysis, multi-omics integration, and AI-supported toxicological risk assessment. Studies using AI to investigate drug–brain interactions, individual susceptibility, emerging contaminants, or translational applications are also encouraged.
By integrating pharmacology, toxicology, neuroscience, clinical medicine, environmental health, and AI, this Special Issue aims to promote multidisciplinary approaches to understanding, predicting, and addressing neurological disorders and toxicological risks.
Keywords
Neuropharmacology; Neurotoxicology; Artificial intelligence; Machine learning; Neurotoxicity; Neuroprotection; Neuroinflammation; Environmental neurotoxicants; Drug safety; Pharmacokinetics and pharmacodynamics; Toxicological risk assessment; Computational toxicology
Manuscript Submission Information
Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (neurobiology@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.
Welcome your submission!
- Journal Metrics
-
2025 
CiteScore SJR SNIP 1.8 0.261 0.274 - Newsletter